AU2004249697B2 - Thiazoline derivatives as selective androgen receptor modulators (SARMS) - Google Patents

Thiazoline derivatives as selective androgen receptor modulators (SARMS) Download PDF

Info

Publication number
AU2004249697B2
AU2004249697B2 AU2004249697A AU2004249697A AU2004249697B2 AU 2004249697 B2 AU2004249697 B2 AU 2004249697B2 AU 2004249697 A AU2004249697 A AU 2004249697A AU 2004249697 A AU2004249697 A AU 2004249697A AU 2004249697 B2 AU2004249697 B2 AU 2004249697B2
Authority
AU
Australia
Prior art keywords
phenyl
lower alkyl
group
trifluoromethyl
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2004249697A
Other languages
English (en)
Other versions
AU2004249697A1 (en
Inventor
Raymond A. Ng
Zhihua Sui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of AU2004249697A1 publication Critical patent/AU2004249697A1/en
Application granted granted Critical
Publication of AU2004249697B2 publication Critical patent/AU2004249697B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
AU2004249697A 2003-06-13 2004-06-12 Thiazoline derivatives as selective androgen receptor modulators (SARMS) Ceased AU2004249697B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47871203P 2003-06-13 2003-06-13
US60/478,712 2003-06-13
PCT/US2004/018665 WO2004113309A1 (en) 2003-06-13 2004-06-12 Thiazoline derivatives as selective androgen receptor modulators (sarms)

Publications (2)

Publication Number Publication Date
AU2004249697A1 AU2004249697A1 (en) 2004-12-29
AU2004249697B2 true AU2004249697B2 (en) 2010-04-22

Family

ID=33539114

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2004249697A Ceased AU2004249697B2 (en) 2003-06-13 2004-06-12 Thiazoline derivatives as selective androgen receptor modulators (SARMS)

Country Status (14)

Country Link
US (1) US20050014952A1 (enExample)
EP (1) EP1656360B1 (enExample)
JP (1) JP4898446B2 (enExample)
CN (1) CN1835937B (enExample)
AT (1) ATE370133T1 (enExample)
AU (1) AU2004249697B2 (enExample)
CA (1) CA2528764A1 (enExample)
CY (1) CY1106973T1 (enExample)
DE (1) DE602004008300T2 (enExample)
DK (1) DK1656360T3 (enExample)
ES (1) ES2291906T3 (enExample)
PL (1) PL1656360T3 (enExample)
PT (1) PT1656360E (enExample)
WO (1) WO2004113309A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4969451B2 (ja) * 2004-11-16 2012-07-04 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 選択的アンドロゲン受容体モジュレーター（ｓａｒｍ）として有用な新規な複素環誘導体
US7709516B2 (en) 2005-06-17 2010-05-04 Endorecherche, Inc. Helix 12 directed non-steroidal antiandrogens
US9284345B2 (en) 2007-04-12 2016-03-15 Endorecherche, Inc. 17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators
HK1208875A1 (en) * 2012-01-12 2016-03-18 耶鲁大学 Compounds & methods for the enhanced degradation of targeted proteins & other polypeptides by an e3 ubiquitin ligase
CN103450112B (zh) * 2013-08-07 2019-09-13 华东理工大学 一种n-桥连接的含氮五元杂环化合物及其制备与用途
US9682960B2 (en) 2013-12-19 2017-06-20 Endorecherche, Inc. Non-steroidal antiandrogens and selective androgen receptor modulators with a pyridyl moiety
CN112566666A (zh) 2018-05-14 2021-03-26 努瓦申生物公司 靶向抗癌核激素受体的化合物
AU2020274113A1 (en) 2019-05-14 2021-11-11 Nuvation Bio Inc. Anti-cancer nuclear hormone receptor-targeting compounds
WO2021097046A1 (en) 2019-11-13 2021-05-20 Nuvation Bio Inc. Anti-cancer nuclear hormone receptor-targeting compounds
JP2024510792A (ja) 2021-03-23 2024-03-11 ニューベイション・バイオ・インコーポレイテッド 抗がん核内ホルモン受容体標的化化合物
JP2024516024A (ja) 2021-05-03 2024-04-11 ニューベイション・バイオ・インコーポレイテッド 抗がん核内ホルモン受容体標的化化合物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002016310A1 (en) * 2000-08-24 2002-02-28 The University Of Tennessee Research Corporation Selective androgen receptor modulators and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ279591A (en) * 1994-01-24 1997-04-24 Du Pont 1,3-oxazoline or-thiazoline derivatives; arthropodicidal compositions therefrom
US6403623B1 (en) * 1999-05-27 2002-06-11 Unuversity Of Notre Dame Du Lac Heterocyclic antituberculosis agents

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002016310A1 (en) * 2000-08-24 2002-02-28 The University Of Tennessee Research Corporation Selective androgen receptor modulators and methods of use thereof

Also Published As

Publication number Publication date
DE602004008300D1 (de) 2007-09-27
CA2528764A1 (en) 2004-12-29
DK1656360T3 (da) 2007-12-27
CY1106973T1 (el) 2012-09-26
AU2004249697A1 (en) 2004-12-29
CN1835937B (zh) 2012-07-18
PT1656360E (pt) 2007-10-22
PL1656360T3 (pl) 2008-01-31
ATE370133T1 (de) 2007-09-15
EP1656360A1 (en) 2006-05-17
US20050014952A1 (en) 2005-01-20
WO2004113309A1 (en) 2004-12-29
JP2007501287A (ja) 2007-01-25
EP1656360B1 (en) 2007-08-15
ES2291906T3 (es) 2008-03-01
DE602004008300T2 (de) 2008-05-08
CN1835937A (zh) 2006-09-20
JP4898446B2 (ja) 2012-03-14

Similar Documents

Publication Publication Date Title
CA2683557C (en) Inhibitors of histone deacetylase
AU2001271022B2 (en) Propane-1,3-dione derivatives
JP4605800B2 (ja) 新規化合物および治療におけるその使用
KR20100095430A (ko) 히스톤 탈아세틸화효소의 저해물질
AU627203B2 (en) Ethylenediamine monoamide derivatives
EP1863804A1 (en) Inhibitors of histone deacetylase
AU2009290849B2 (en) Novel imidazolidine compounds as androgen receptor modulators
AU2004249697B2 (en) Thiazoline derivatives as selective androgen receptor modulators (SARMS)
WO2007143822A1 (en) Sulfamide and sulfamate derivatives as histone deacetylase inhibitors
US6313301B1 (en) Thienopyridine derivatives, their intermediates and production thereof
KR101386679B1 (ko) 신규한 아릴피페라진-함유 이미다졸 4-카복사마이드 유도체 및 이를 포함하는 약학 조성물
CA2598133A1 (en) Pgd2 receptor antagonists for the treatment of inflammatory diseases
GB2216517A (en) 1-(3-aryl-prop-2-enyl)-4-tricyclyl-piperazines
JP4381311B2 (ja) 置換ベンゾチアゾール誘導体の環化方法
JP4746840B2 (ja) アンドロゲン受容体モジュレーターとしての２−（キノロニル）−縮合複素環化合物
CA2719074C (en) Novel method for the production of sulphonylpyrroles as hdac inhibitors
KR101577314B1 (ko) 키나제 억제제로서의 접합된 티아졸 유도체
MXPA05013599A (en) Thiazoline derivatives as selective androgen receptor modulators (sarms)
US5468761A (en) 4-methyl-5-substituted-1,3-oxazoles having anti-inflammatory activity
Liang et al. Synthesis and Biological Activity of Some 1, 3‐Dihydro‐2H‐3‐benzazepin‐2‐ones with a Piperazine Moiety as Bradycardic Agents
EP0145304B1 (en) Tetrahydro-beta-carboline derivatives and process for the preparation thereof
JP2008531564A (ja) ステロイドホルモン核受容体のモジュレーターとしてのスピロ含有化合物および組成物

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired